Correction: Apixaban Versus Rivaroxaban in Patients With Atrial Fibrillation and Valvular Heart Disease
- PMID: 37487217
- DOI: 10.7326/L23-0266
Correction: Apixaban Versus Rivaroxaban in Patients With Atrial Fibrillation and Valvular Heart Disease
Erratum for
-
Apixaban Versus Rivaroxaban in Patients With Atrial Fibrillation and Valvular Heart Disease : A Population-Based Study.Ann Intern Med. 2022 Nov;175(11):1506-1514. doi: 10.7326/M22-0318. Epub 2022 Oct 18. Ann Intern Med. 2022. PMID: 36252244 Free PMC article. Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources